curculigoside has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Hou, J; Jiang, W; Lin, F; Ye, L; Zhong, Y; Zhu, H | 1 |
| Fu, F; Hou, J; Jiang, W; Tian, J; Zhu, H | 1 |
2 other study(ies) available for curculigoside and Brain Ischemia
| Article | Year |
|---|---|
Mechanisms of angiogenesis in a Curculigoside A-treated rat model of cerebral ischemia and reperfusion injury.
Topics: Animals; Benzoates; beta Catenin; Blood-Brain Barrier; Brain Ischemia; Cell Proliferation; CREB-Binding Protein; Early Growth Response Protein 3; Endothelial Cells; Extracellular Matrix Proteins; Glucosides; Intercellular Signaling Peptides and Proteins; Male; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Reperfusion Injury; Signal Transduction; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Wnt Proteins; Wnt-5a Protein | 2015 |
Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo.
Topics: Animals; Benzoates; Blood-Brain Barrier; Blotting, Western; Brain Ischemia; Cell Line, Tumor; Glucosides; HMGB1 Protein; Humans; Male; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction | 2011 |